308 related articles for article (PubMed ID: 26294352)
1. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
[TBL] [Abstract][Full Text] [Related]
2. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
3. Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population.
Hashemi M; Amininia S; Ebrahimi M; Hashemi SM; Taheri M; Ghavami S
BMC Res Notes; 2014 Dec; 7():895. PubMed ID: 25491902
[TBL] [Abstract][Full Text] [Related]
4. Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.
Choi BJ; Yoon JH; Kim O; Choi WS; Nam SW; Lee JY; Park WS
World J Gastroenterol; 2015 Aug; 21(31):9328-36. PubMed ID: 26309358
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
[TBL] [Abstract][Full Text] [Related]
6. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
Essa ES; Alagizy HA
Tumori; 2018 Jun; 104(3):165-171. PubMed ID: 28967095
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte telomere length and
Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
[No Abstract] [Full Text] [Related]
8. Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases.
Pandith AA; Wani ZA; Qasim I; Afroze D; Manzoor U; Amin I; Baba SM; Koul A; Anwar I; Mohammad F; Bhat AR; Shah P
J Gene Med; 2020 Nov; 22(11):e3260. PubMed ID: 32783258
[TBL] [Abstract][Full Text] [Related]
9. Telomere length and
Mervic A; Goricar K; Blagus T; Franko A; Trebusak-Podkrajsek K; Fikfak MD; Dolzan V; Kovac V
Radiol Oncol; 2024 Mar; 58(1):87-98. PubMed ID: 38378028
[TBL] [Abstract][Full Text] [Related]
10. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
11. hTERT cancer risk genotypes are associated with telomere length.
Melin BS; Nordfjäll K; Andersson U; Roos G
Genet Epidemiol; 2012 May; 36(4):368-72. PubMed ID: 22539396
[TBL] [Abstract][Full Text] [Related]
12. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
[TBL] [Abstract][Full Text] [Related]
13. The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma.
Sitaram RT; Cairney CJ; Grabowski P; Keith WN; Hallberg B; Ljungberg B; Roos G
Int J Cancer; 2009 Aug; 125(4):783-90. PubMed ID: 19384955
[TBL] [Abstract][Full Text] [Related]
14. Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer.
Oztas E; Kara H; Kara ZP; Aydogan MU; Uras C; Ozhan G
Genet Test Mol Biomarkers; 2016 Aug; 20(8):459-64. PubMed ID: 27336831
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.
Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725
[TBL] [Abstract][Full Text] [Related]
17. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
[TBL] [Abstract][Full Text] [Related]
18. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N
PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590
[TBL] [Abstract][Full Text] [Related]
19. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
Liu Y; Li Z; Tang X; Li M; Shi F
Recent Pat Anticancer Drug Discov; 2019; 14(3):268-279. PubMed ID: 31538903
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
